gdc

Leukemia

A Deadly Cancer Becoming a Chronic Disease
Leukemia
Chronic myeloid leukemia (CML) is a blood cancer that results from a genetic abnormality that causes the production of too many white blood cells in the bone marrow. However, CML is not a genetic disease that runs in families.
My Journey with LGL Leukemia
LeukemiaPatient Stories
Tina Cancio, founder of the LGL Leukemia Foundation, recalls her battle with LGL Leukemia.
What You Need to Know About Leukemia
Leukemia
An overview of leukemia with information about risk factors, common symptoms, and treatments options, including immunotherapy.
What You Need to Know About Leukemia
Leukemia
A rundown of the 4 main types of leukemia: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML).
Drugs for Leukemia
Leukemia
Here are the financial support services available to patients receiving treatment for Leukemia.
Celebrating Progress and Sharing Hope: The Leukemia & Lymphoma Society to Host Free Rocky Mountain Blood Cancer Conference for Blood Cancer Patients, Survivors and Caregivers
LeukemiaLymphomaNewsworthy
The Leukemia & Lymphoma Society (LLS) will be hosting its 8th Annual Rocky Mountain Blood Cancer Conference on Saturday, April 7, 2018, at the Hyatt Regency Aurora-Denver Conference Center. LLS Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals.
Lessons in Love and Resurrection: My Journey Through Leukemia
LeukemiaPatient Stories
Shaun Willson’s story is one of daring independence and strength, as he championed through an acute myeloid leukemia diagnosis while also being the primary caregiver to his wife, Deborah, during her battle with metastatic cancer.
Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation
LeukemiaNewsworthyWeb Exclusives
This is the first treatment that targets patients with AML and the FLT3-ITD mutation. In this clinical trial, patients who received quizartinib lived longer without disease progression than those receiving chemotherapy.
Growing Role of Biomarkers in the Treatment of Patients with Acute Myeloid Leukemia
Cancer BiomarkersLeukemia
In recent years, new treatments for acute myeloid leukemia have improved outcomes. In 2017, 2 new drugs were approved for patients with this type of blood cancer linked to a specific biomarker.
Page 1 of 2
Results 1 - 10 of 16

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country